Allsup, D., & Molica, S. (2023). Acalabrutinib is an effective treatment for immune thrombocytopenia associated with chronic lymphocytic leukemia, a case report. Leukemia & Lymphoma, https://doi.org/10.1080/10428194.2023.2199341